Emerging Targets & Therapeutics in the Treatment of Psychostimulant Abuse book cover

Emerging Targets & Therapeutics in the Treatment of Psychostimulant Abuse

This new volume of Advances in Pharmacology presents the emerging targets and therapeutics in the treatment of psychostimulant abuse. With a variety of chapters and the best authors in the field, the volume is an essential resource for pharmacologists, immunologists and biochemists alike.


Pharmacologists, immunologists, and biochemists

Included in series
Advances in Pharmacology

Hardbound, 656 Pages

Published: February 2014

Imprint: Academic Press

ISBN: 978-0-12-420118-7


  • 1. Glial Modulators as Potential Treatments of Psychostimulant Abuse
     Patrick M. Beardsley and Kurt F. Hauser
    2. The Vesicular Monoamine Transporter-2 (VMAT2): An Important Pharmacological Target for the Discovery of Novel Therapeutics to Treat Methamphetamine Abuse
     Justin R. Nickell, Kiran B. Siripurapu, Ashish Vartak, Peter A. Crooks & Linda P. Dwoskin
    3. Customizing Monoclonal Antibodies for the Treatment of Methamphetamine Abuse: Current and Future Applications
     Eric C. Peterson, W. Brooks Gentry, and S. Michael Owens
    4. Monoamine Transporter Inhibitors and Substrates as Treatments for Stimulant Abuse
     Leonard L. Howell and S. Stevens Negus
    5. Bupropion and Bupropion Analogs as Treatments for CNS Disorders
     F. Ivy Carroll, Bruce E. Blough, S. Wayne Mascarella, Hernán A. Navarro, Ronald J. Lukas and M. Imad Damaj
    6. The Role of Guanfacine as a Therapeutic Agent to Address Stress-related Pathophysiology in Cocaine Dependent Individuals
     Helen Fox and Rajita Sinha
    7. Beyond Small Molecule SAR – Using the Dopamine D3 Receptor Crystal Structure to Guide Drug Design
     Thomas M. Keck, Caitlin Burzynski, Lei Shi and Amy Hauck Newman
    8. Dopamine D4 Receptors in Psychostimulant Addiction
     Patricia Di Ciano, David Grandy and Bernard Le Foll
    9. Sigma Receptors as Potential Therapeutic Targets to Mitigate Psychostimulant Effects
     Rae R. Matsumoto, Linda Nguyen, Nidhi Kaushal and Matthew J. Robson
    10. Mixed Kappa/Mu Partial Opioid Agonists as Potential Treatments for Cocaine Dependence
     Jean M. Bidlack
    11. The Combination of Metyrapone and Oxazepam for the Treatment of Cocaine and Other Drug Addictions
     Nicholas E Goeders, Glenn F Guerin and Christopher D Schmoutz
    12. Salvinorin A Analogs and Other Kappa Opioid Receptor Compounds as Treatments for Cocaine Abuse
     Bronwyn M Kivell, Amy WM Ewald and Thomas E Prisinzano
    13. Nicotinic Receptor Antagonists as Treatments for Nicotine Abuse
     Peter A. Crooks, Michael T. Bardo and Linda P. Dwoskin
    14. New Directions in Nicotine Vaccine Design and Use
     Paul R. Pentel and Mark G. LeSage
    15. Bath Salts, Mephedrone, and Methylenedioxypyrovalerone as Emerging Illicit Drugs That Will Need Targeted Therapeutic Intervention
     Richard A. Glennon


advert image